Evidence map›Paper›PMID 41986322›Full record

ArticleNature communications2026

Author Correction: Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution.

Nathalie Khoury, Michelle E Pizzo, Claire B Discenza, David Joy, David Tatarakis, Mihail Ivilinov Todorov, Moritz Negwer, Connie Ha, Gabrielly L De Melo, Lily Sarrafha and 24 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors.

Nathalie KhouryDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Michelle E PizzoDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.ORCID http://orcid.org/0000-0003-4219-5996
Claire B DiscenzaDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
David JoyDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.ORCID http://orcid.org/0000-0001-9941-9538
David TatarakisDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Mihail Ivilinov TodorovDeep Piction, 81377, Munich, Germany.
Moritz NegwerDeep Piction, 81377, Munich, Germany.
Connie HaDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Gabrielly L De MeloDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Lily SarrafhaDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.ORCID http://orcid.org/0000-0002-6168-2119
Matthew J SimonDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Darren ChanDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Roni ChauDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Kylie S ChewDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.ORCID http://orcid.org/0000-0003-4752-009X
Johann ChowDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.ORCID http://orcid.org/0009-0001-8170-6392
Allisa ClemensDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Yaneth Robles-ColmenaresDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Jason C DugasDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Joseph DuqueDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Doris KalteneckerDeep Piction, 81377, Munich, Germany.
Holly KaneDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Amy LeungDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Edwin LozanoDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Arash MoshkforoushDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Elysia RocheDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Thomas SandmannDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.ORCID http://orcid.org/0000-0002-6601-8890
Mabel TongDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Kaitlin XaDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Yinhan ZhouDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Joseph W LewcockDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.ORCID http://orcid.org/0000-0003-3012-7881
Ali ErtürkDeep Piction, 81377, Munich, Germany.
Robert G ThorneDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Meredith E K CalvertDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA. calvert@dnli.com.ORCID http://orcid.org/0000-0003-2893-959X
Y Joy Yu ZucheroDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA. zuchero@dnli.com.ORCID http://orcid.org/0000-0001-5183-7968

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41986322
PMCPMC13083904

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.